Alison Kiley is Director & 10% at Aegerion Pharmaceuticals, Inc. (AEGR). They have made 2 open-market trades across 1 company since 2010, most recently 2011-08-09.
CIK 0001341637
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $3.1M since 2010, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AEGR | 2,690,251 | $5.3M |
Shares reported on the most recent Form 4, priced at the 2011-08-09 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.